13F HOLDINGS REPORT
Vestal Point Capital, LP
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001974915-24-000006
Total Value
$1.34B
Positions
60
Other Managers
0
Confidential Omitted
No
Holdings (60)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Jazz Pharmaceuticals PLC | JAZZ | 1,500,000 | $160.1M | 11.94% |
| 2 | Cytokinetics Inc | CYTK | 2,075,000 | $112.4M | 8.38% |
| 3 | Ascendis Pharma A/S | ASND | 750,000 | $102.3M | 7.63% |
| 4 | Ultragenyx Pharmaceutical Inc | RARE | 1,800,000 | $74.0M | 5.52% |
| 5 | Globus Medical Inc | GMED | 900,000 | $61.6M | 4.60% |
| 6 | Insmed Inc | INSM | 750,000 | $50.3M | 3.75% |
| 7 | BeiGene Ltd | BEIGF | 350,000 | $49.9M | 3.72% |
| 8 | Soleno Therapeutics Inc | SLNO | 1,200,000 | $49.0M | 3.65% |
| 9 | Exact Sciences Corp | 30063P105 | 925,000 | $39.1M | 2.91% |
| 10 | Arcellx Inc | ACLX | 675,000 | $37.3M | 2.78% |
| 11 | Immatics NV | IMTX | 2,750,000 | $32.0M | 2.38% |
| 12 | Janux Therapeutics Inc | JANX | 725,000 | $30.4M | 2.26% |
| 13 | Astria Therapeutics Inc | 04635X102 | 3,250,000 | $29.6M | 2.21% |
| 14 | KalVista Pharmaceuticals Inc | KALV | 2,300,000 | $27.1M | 2.02% |
| 15 | Savara Inc | SVRA | 6,490,000 | $26.2M | 1.95% |
| 16 | iTeos Therapeutics Inc | 46565G104 | 1,750,000 | $26.0M | 1.94% |
| 17 | Applied Therapeutics Inc | 03828A101 | 5,430,000 | $25.4M | 1.89% |
| 18 | Axsome Therapeutics Inc | AXSM | 300,000 | $24.1M | 1.80% |
| 19 | Structure Therapeutics Inc | GPCR | 560,000 | $22.0M | 1.64% |
| 20 | Liquidia Corp | LQDA | 1,830,000 | $22.0M | 1.64% |
| 21 | ALX Oncology Holdings Inc | ALXO | 3,600,000 | $21.7M | 1.62% |
| 22 | uniQure NV | QURE | 4,750,000 | $21.3M | 1.59% |
| 23 | Bristol-Myers Squibb Co | CELG-RI | 500,000 | $20.8M | 1.55% |
| 24 | Xenon Pharmaceuticals Inc | XENE | 525,000 | $20.5M | 1.53% |
| 25 | Praxis Precision Medicines Inc | PRAX | 440,000 | $18.2M | 1.36% |
| 26 | Day One Biopharmaceuticals Inc | DAWN | 1,250,000 | $17.2M | 1.28% |
| 27 | Inari Medical Inc | 45332Y109 | 350,000 | $16.9M | 1.26% |
| 28 | Dianthus Therapeutics Inc | DNTH | 600,000 | $15.5M | 1.16% |
| 29 | Solid Biosciences Inc | SLDB | 2,665,000 | $15.1M | 1.13% |
| 30 | Lexeo Therapeutics Inc | LXEO | 840,000 | $13.5M | 1.00% |
| 31 | Apellis Pharmaceuticals Inc | APLS | 335,000 | $12.9M | 0.96% |
| 32 | Immunome Inc | IMNM | 1,000,000 | $12.1M | 0.90% |
| 33 | Denali Therapeutics Inc | DNLI | 500,000 | $11.6M | 0.87% |
| 34 | Nurix Therapeutics Inc | NRIX | 500,000 | $10.4M | 0.78% |
| 35 | Black Diamond Therapeutics Inc | BDTX | 2,100,000 | $9.8M | 0.73% |
| 36 | BioNTech SE | BNTX | 100,000 | $8.0M | 0.60% |
| 37 | Inspire Medical Systems Inc | 457730109 | 60,000 | $8.0M | 0.60% |
| 38 | Pacira BioSciences Inc | PCRX | 280,000 | $8.0M | 0.60% |
| 39 | Dyne Therapeutics Inc | DYN | 225,000 | $7.9M | 0.59% |
| 40 | Fulcrum Therapeutics Inc | FULC | 1,160,000 | $7.2M | 0.54% |
| 41 | Alto Neuroscience Inc | ANRO | 620,000 | $6.6M | 0.49% |
| 42 | Fate Therapeutics Inc | FATE | 2,000,000 | $6.6M | 0.49% |
| 43 | Allogene Therapeutics Inc | ALLO | 2,200,000 | $5.1M | 0.38% |
| 44 | Passage Bio Inc | PASG | 6,052,000 | $4.8M | 0.36% |
| 45 | Voyager Therapeutics Inc | VYGR | 600,000 | $4.7M | 0.35% |
| 46 | Galapagos NV | GLPGF | 180,000 | $4.5M | 0.33% |
| 47 | Zymeworks Inc | ZYME | 440,000 | $3.7M | 0.28% |
| 48 | Relmada Therapeutics Inc | RLMD | 1,200,000 | $3.6M | 0.27% |
| 49 | MacroGenics Inc | MGNX | 800,000 | $3.4M | 0.25% |
| 50 | Monte Rosa Therapeutics Inc | GLUE | 890,000 | $3.3M | 0.25% |
| 51 | Ventyx Biosciences Inc | 92332V107 | 1,315,000 | $3.0M | 0.23% |
| 52 | PTC Therapeutics Inc | PTCT | 90,000 | $2.8M | 0.21% |
| 53 | Verve Therapeutics Inc | 92539P101 | 500,000 | $2.4M | 0.18% |
| 54 | Iovance Biotherapeutics Inc | IOVA | 300,000 | $2.4M | 0.18% |
| 55 | Prime Medicine Inc | PRME | 450,000 | $2.3M | 0.17% |
| 56 | Chimerix Inc | 16934W106 | 1,400,000 | $1.2M | 0.09% |
| 57 | Achilles Therapeutics PLC | 00449L102 | 1,500,000 | $1.2M | 0.09% |
| 58 | Atara Biotherapeutics Inc | ATRA | 112,000 | $952,000 | 0.07% |
| 59 | Reneo Pharmaceuticals Inc | 75974E103 | 545,000 | $822,950 | 0.06% |
| 60 | Newamsterdam Pharma Co NV | NAMSW | 25,000 | $480,250 | 0.04% |